REG - Venture Life Group - Director/PDMR Shareholding

Venture LifeAnnouncement

29/12/2021 12:35

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211229:nRSc9644Wa&default-theme=true

RNS Number : 9644W  Venture Life Group PLC  29 December 2021

29 December 2021

VENTURE LIFE GROUP PLC

("Venture Life" "VLG" or the "Group")

Director Dealings

Venture Life Group plc (AIM: VLG), a leader in developing, manufacturing and
commercialising products for the international self-care market, announces
that on 24 December 2021 certain of the Company's Directors purchased shares
as follow:

 Name                          No. of Shares Purchased  Price per share  Resultant holding post transaction (%)

 Jerry Randall,                100,000                  30.15p           2,084,865 (1.7%)

 Chief Executive Officer

 Sharon Collins,               100,000                  30.15p           1,209,977 (1.0%)

 Chief Commercial Officer

 Gianluca Braguti,             100,000                  30.15p           3,742,730 (3.0%)

 Chief Manufacturing Officer

 

 

For further information, please contact:

 

 Venture Life Group PLC                                 +44 (0) 1344 578004
 Jerry Randall, Chief Executive Officer

 Daniel Wells, Chief Financial Officer

 Cenkos Securities plc (Nomad and Broker)               +44 (0) 20 7397 8900
 Stephen Keys / Camilla Hume
 Russell Kerr / Michael Johnson (Sales)

  N+1 Singer (Joint Broker)                             +44 (0) 20 7496 3000
  Shaun Dobson / Alaina Wong (Corporate Finance)
  Jonathan Dighe (Sales)

 

About Venture Life (www.venture-life.com (http://www.venture-life.com/) )

Venture Life is an international consumer self-care company focused on
developing, manufacturing and commercialising products for the global
self-care market. With operations in the UK, Italy, The Netherlands and
Sweden, the Group's product portfolio includes some key products such as the
UltraDEX and Dentyl oral care product ranges, the Balance Active range in the
area of women's intimate healthcare, the Lift and Glucogel product ranges for
hypoglycaemia, products for fungal infections and proctology, and
dermo-cosmetics for addressing the signs of ageing. Its products are sold in
over 90 countries worldwide.

The products, which are typically recommended by pharmacists or healthcare
practitioners, are available primarily through pharmacies and grocery
multiples. In the UK and The Netherlands these are supplied direct by the
company to retailers, elsewhere they are supplied by the Group's international
distribution partners.

Through its two Development & Manufacturing operations in Italy and
Sweden, the Group also provides development and manufacturing services to
companies in the medical devices and cosmetic sectors.

 

 

The Company makes the following disclosures in accordance with article 19(3)
of the Market Abuse Regulation:

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Jerry Randall

 2    Reason for the notification

 a)   Position/status                                              Chief Executive Officer

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Venture Life Group plc

 b)   LEI                                                          213800S8CZUPLAB2KC70

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary Shares of 0.3p each in Venture Life Group plc

      Identification code

                                                                   GB00BFPM8908

 b)   Nature of the transaction                                    Purchase of ordinary shares

 c)   Price(s) and volume(s)                                       100,000 ordinary shares at 30.15 pence per share

 d)   Aggregated information                                       See above

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      24 December 2021

 f)   Place of the transaction                                     London Stock Exchange

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Sharon Collins

 2    Reason for the notification

 a)   Position/status                                              Chief Commercial Officer

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Venture Life Group plc

 b)   LEI                                                          213800S8CZUPLAB2KC70

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary Shares of 0.3p each in Venture Life Group plc

      Identification code

                                                                   GB00BFPM8908

 b)   Nature of the transaction                                    Purchase of ordinary shares

 c)   Price(s) and volume(s)                                       100,000 ordinary shares at 30.15 pence per share

 d)   Aggregated information                                       See above

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      24 December 2021

 f)   Place of the transaction                                     London Stock Exchange

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Gianluca Braguti

 2    Reason for the notification

 a)   Position/status                                              Chief Manufacturing Officer

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Venture Life Group plc

 b)   LEI                                                          213800S8CZUPLAB2KC70

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary Shares of 0.3p each in Venture Life Group plc

      Identification code

                                                                   GB00BFPM8908

 b)   Nature of the transaction                                    Purchase of ordinary shares

 c)   Price(s) and volume(s)                                       100,000 ordinary shares at 30.15 pence per share

 d)   Aggregated information                                       See above

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      24 December 2021

 f)   Place of the transaction                                     London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFVFFFLAFIL